Kazia Therapeutics (KZIA) Common Equity (2009 - 2025)
Kazia Therapeutics (KZIA) posted Common Equity of $30.5 million for Q4 2025, up 473.85% on a QoQ basis from $5.3 million in Q2 2025, and up 1125.28% year-over-year from $2.5 million in Q4 2024.
Kazia Therapeutics (KZIA) Common Equity (2009 - 2025) Analysis & Trends
Kazia Therapeutics' Common Equity history runs 17 years deep, the most recent figure standing at $30.5 million for Q4 2025.
- Quarterly Common Equity rose 1125.28% year-over-year to $30.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.5 million (up 1125.28% YoY) and the FY2025 annual result came in at $5.3 million, up 180.54% from the prior year.
- Common Equity was $30.5 million for Q4 2025 at Kazia Therapeutics, up from $5.3 million in the prior quarter.
- Across five years, Common Equity topped out at $30.5 million in Q4 2025 and bottomed at -$6.6 million in Q2 2024.
- A 5-year average of $11.1 million and a median of $7.8 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2024 — Common Equity tumbled 181.97% — and 2025, when it soared 1125.28%.
- Kazia Therapeutics' Common Equity stood at $18.4 million in 2021, then sank by 58.73% to $7.6 million in 2022, then plunged by 54.94% to $3.4 million in 2023, then declined by 27.39% to $2.5 million in 2024, then surged by 1125.28% to $30.5 million in 2025.
- Business Quant data shows KZIA's Common Equity at $30.5 million in Q4 2025, $5.3 million in Q2 2025, and $2.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | 30.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.51 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Dec 31, 2024 | 2.49 Mn |
| Jun 30, 2024 | -6.60 Mn |
| Dec 31, 2023 | 3.43 Mn |
| Jun 30, 2023 | 8.05 Mn |
| Dec 31, 2022 | 7.61 Mn |
| Jun 30, 2022 | 13.09 Mn |
| Dec 31, 2021 | 18.44 Mn |
| Jun 30, 2021 | 29.15 Mn |
| Dec 31, 2020 | 23.15 Mn |
| Jun 30, 2020 | 9.26 Mn |
| Dec 31, 2019 | 8.37 Mn |
| Jun 30, 2019 | 9.94 Mn |
| Dec 31, 2018 | 13.18 Mn |
| Jun 30, 2018 | 14.57 Mn |
| Jun 30, 2017 | 19.03 Mn |
| Dec 31, 2016 | 19.33 Mn |
| Jun 30, 2016 | 18.92 Mn |
| Dec 31, 2015 | 32.14 Mn |